中文 | English
Return
Total: 393 , 1/40
Show Home Prev Next End page: GO
Author:(Shu-yi XU)

1.Progresses and issues of corneal tissue engineering with bone marrow mesenchymal stem cells

Shu-yi, XU

Chinese Journal of Experimental Ophthalmology 2013;(2):196-200

3.Analysis of the distribution and drug resistance of pathogens in patients with acute exacerbation of chronic obstructive pulmonary disease

Yi XU ; Bailing ZHANG ; Shu SHANG

Chongqing Medicine 2015;(32):4507-4509

4.Inhibition of mevastatin on inflammation and differentiation of orbital preadipocytes in thyroid-associated ophthalmopathy

Wen-shu, YI ; Xue-liang, XU

Chinese Journal of Experimental Ophthalmology 2011;29(10):907-912

5.Practice of Clinical Pharmacists Participating in the Treatment of a Case of Severe Ulcerative Colitis dur-ing Late Pregnancy

Yi XU ; He SHU ; Qian WANG ; Li ZHANG ; Jianjiang XU

China Pharmacy 2016;27(8):1131-1132,1133

6.Protection against Myocardial Ischemia/Reperfusion Injury in Rats by Pretreatment with Paeoniflorin

Wenxia LIU ; Junlian SHU ; Li XU ; Junping CAO ; Yi MA

China Pharmacist 2015;(6):926-928

7.Differentiation of human umbilical cord mesenchymal stem cells into corneal epithelium like cells

Shu-yi, XU ; Guang-hui, HOU ; Jing, WU ; Jin-tang, XU

Chinese Journal of Experimental Ophthalmology 2012;(10):882-887

8.Working process in elimination of iodine deficiency disorders and related issues from 2003 to 2010

Shu-hui, XU ; Cai-yun, CHANG ; Xing-yi, GENG ; Hua-ru, XU ; Xue-feng, BIAN

Chinese Journal of Endemiology 2012;31(4):434-436

9.The in vitro anti-atherosclerotic activity of compound E0869.

Xiao WANG ; Chang LIU ; Peng LIU ; Ni LI ; Yan-Ni XU ; Shu-Yi SI

Acta Pharmaceutica Sinica 2015;50(4):440-446

10.Extension of service life for CT tubes

Yi ZHU ; Shu-Bo YANG ; Xin-Yun RUAN ; Zhi-Rong XU ;

Chinese Medical Equipment Journal 2003;0(10):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 393 , 1/40 Show Home Prev Next End page: GO